Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT)

v3.10.0.1
CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)
Total
Previously Reported [Member]
Restatement Adjustment [Member]
Common Stock [Member]
Common Stock [Member]
Previously Reported [Member]
Additional Paid-In Capital [Member]
Additional Paid-In Capital [Member]
Previously Reported [Member]
Stock holders Notes Receivable Member [Member]
Accumulated Other Comprehensive Income [Member]
Accumulated Other Comprehensive Income [Member]
Previously Reported [Member]
Accumulated Deficit [Member]
Accumulated Deficit [Member]
Previously Reported [Member]
Accumulated Deficit [Member]
Restatement Adjustment [Member]
Series B Preferred Stock [Member]
Series B Preferred Stock [Member]
Previously Reported [Member]
Series B Preferred Stock [Member]
Common Stock [Member]
Series B Preferred Stock [Member]
Additional Paid-In Capital [Member]
Series B Preferred Stock [Member]
Preferred Stock [Member]
Series C Preferred Stock [Member]
Series C Preferred Stock [Member]
Previously Reported [Member]
Series C Preferred Stock [Member]
Common Stock [Member]
Series C Preferred Stock [Member]
Additional Paid-In Capital [Member]
Series C Preferred Stock [Member]
Preferred Stock [Member]
Balance at Dec. 31, 2016 $ (329,421)     $ 101,309   $ 78,106,645   $ (58,824) $ 120,187   $ (78,598,738)     $ 0         $ 0        
Balance (in shares) at Dec. 31, 2016       10,130,883                   0         0        
Stock-Based Compensation 870,308         870,308                                  
Cancellation of Stockholder Note Receivable 58,824             58,824                              
Issuance of Common Stock in Offerings, Net of Offering Costs 8,611,683     $ 59,788   8,551,895                                  
Issuance of Common Stock in Offerings, Net of Offering Costs (in shares)       5,978,817                                      
Issuance of Series B Preferred Stock, Net of Offering Costs of $246,333 1,977,500         1,977,480               $ 20                  
Issuance of Series B Preferred Stock, Net of Offering Costs of $246,333 (in shares)                           1,995                  
Conversion of Series Preferred Stock 0     $ 9,300   (9,286)               $ (14)                  
Conversion of Series Preferred Stock (in shares)       930,000                   (1,395)                  
Exercise of Common Stock Options 40,718     $ 611   40,107                                  
Exercise of Common Stock Options (in shares)       61,078                                      
Cancellation of Restricted Stock 0     $ 1,030   (1,030)                                  
Cancellation of Restricted Stock (in shares)       103,000                                      
Issuance of Common Stock from Employee Stock Purchase Plan 54,097     $ 535   53,562                                  
Issuance of Common Stock from Employee Stock Purchase Plan (in shares)       53,477                                      
Foreign Currency Translation Adjustment 7,286               7,286                            
Net Loss (13,217,917)                   (13,217,917)                        
Balance at Dec. 31, 2017 7,550,958 $ (1,926,922)   $ 172,573 $ 172,573 89,589,681 $ 89,589,681 $ 0 127,473 $ 127,473 (82,338,775) $ (91,816,655)   $ 6 $ 6       $ 0 $ 0      
Balance (in shares) at Dec. 31, 2017       17,257,255 17,257,255                 600 600       0 0      
Cumulative Effect of Change in Accounting Principle (Note 2)     $ 9,477,880                   $ 9,477,880                    
Stock-Based Compensation 875,287         875,287                                  
Issuance of Common Stock in Offerings, Net of Offering Costs 10,108,762     $ 147,300   9,961,397                         $ 65        
Issuance of Common Stock in Offerings, Net of Offering Costs (in shares)       14,730,000                             6,536        
Conversion of Series Preferred Stock                           $ 0   $ 4,000 $ (3,994) $ (6) $ 0   $ 76,388 $ (76,364) $ (24)
Conversion of Series Preferred Stock (in shares)                               400,000   (600)     7,638,750   (2,444)
Issuance of Common Shares from Warrant Exercises 1,205,825     $ 37,681   1,168,144                                  
Issuance of Common Shares from Warrant Exercises (in shares)       3,768,125                                      
Cancellation of Restricted Stock 0     $ (3)   3                                  
Cancellation of Restricted Stock (in shares)       (252)                                      
Foreign Currency Translation Adjustment 6,858               6,858                            
Net Loss (10,811,423)                   (10,811,423)                        
Balance at Dec. 31, 2018 $ 8,936,267     $ 437,939   $ 101,514,154     $ 134,331   $ (93,150,198)     $ 0         $ 41        
Balance (in shares) at Dec. 31, 2018       43,793,878                   0         4,092